Splenectomy prolongs in vivo survival of erythrocytes differently in spectrin/ankyrin- and band 3-deficient hereditary spherocytosis

Blood

Volumn 100, Issue 6, 2002, Pages 2208-2215

  Reliene, Ramune ^a,b,c,d,e,f   Mariani, Mariagabriella ^a,b,c,d,e,f   Zanella, Alberto ^a,b,c,d,e,f   Reinhart, Walter H ^a,b,c,d,e,f   Leticia Ribeiro, M ^a,b,c,d,e,f   Del Giudice, Emanuele Miraglia ^a,b,c,d,e,f   Perrotta, Silverio ^a,b,c,d,e,f   Iolascon, Achille ^a,b,c,d,e,f   Eber, Stefan ^a,b,c,d,e,f   Lutz, Hans U ^a,b,c,d,e,f  

^a ETH ZURICH   (Switzerland)

^b The Children Hospital   (Switzerland)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

^e UNIVERSITY OF FOGGIA   (Italy)

^f CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; IMMUNOGLOBULIN G; SPECTRIN;

ANTIBODY AFFINITY; ARTICLE; CELL AGING; CELL VACUOLE; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; FEMALE; HEREDITARY SPHEROCYTOSIS; HUMAN; MALE; OPSONIZATION; PRIORITY JOURNAL; SPLENECTOMY;

EID: 0037105613     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v100.6.2208.h81802002208_2208_2215     Document Type: Article

References (56)

1. Hereditary spherocytosis: A review of the clinical and molecular aspects of the disease
2. Red blood cell membrane disorders
3. Molecular genetics of hereditary spherocytosis
4. Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis
5. Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency
6. Modulation of clinical expression and band 3 deficiency in hereditary spherocytosis
7. Red cell membrane disorders in the Japanese population: Clinical, biochemical, electron microscopic, and genetic studies
8. Two distinct truncated variants of ankyrin associated with hereditary spherocytosis
9. High frequency of de novo mutations in ankyrin gene (ANK1) in children with hereditary spherocytosis
10. Characterization of the underlying molecular defect in hereditary spherocytosis associated with spectrin deficiency
11. A 5′ splice region GC mutation in exon 3 of the human beta-spectrin gene leads to decreased levels of beta-spectrin mRNA and is responsible for dominant hereditary spherocytosis (Spectrin Guemene-Penfao)
12. Mutations of conserved arginines in the membrane domain of erythroid band 3 lead to a decrease in membrane-associated band 3 and to the phenotype of hereditary spherocytosis
13. Heterogenous band 3 deficiency in hereditary spherocytosis related to different band 3 gene defects
14. Band 3 Chur: A variant associated with band 3-deficient hereditary spherocytosis and substitution in a highly conserved position of transmembrane segment 11
15. Novel band 3 variants (bands 3 Foggia, Napoli I and Napoli II) associated with hereditary spherocytosis and band 3 deficiency: Status of the D38A polymorphism within the EPB3 locus
16. A variant of the EPB3 gene of the anti-Lepore type in hereditary spherocytosis
17. The red cell membrane
18. Cytoskeletal behaviour in spectrin and in band 3 deficient spherocytic red cells: Evidence for a differentiated splenic conditioning role
19. Membrane cation and anion transport activities in erythrocytes of hereditary spherocytosis: Effects of different membrane protein defects
20. + and water contents
21. Hereditary spherocytosis: The metabolism of erythrocytes in the peripheral blood and in the splenic pulp
22. Hereditary spherocytosis, elliptocytosis, and related disorders
23. Red cell abnormalities in hereditary spherocytosis: Relevance to diagnosis and understanding of the variable expression of clinical severity
24. Deamidation of human erythrocyte protein-4.1: Possible role in aging
25. The removal of leukocytes and platelets from whole blood
26. Density separation of human red blood cells on self forming Percoll gradients: Correlation with cell age
27. Osmotic gradient ektacytometry: Comprehensive characterization of red cell volume and surface maintenance
28. Preferential formation of C3b-IgG complexes in vitro and in vivo from nascent C3b and naturally occurring anti-band 3 antibodies
29. The quantitation of platelet-associated IgG on cohorts of platelets separated from healthy individuals by buoyant density centrifugation
30. Electrophoretic properties of human IgG and its subclasses on sodium dodecyl-sulfate-polyacrylamide gel electrophoresis and immunoblots
31. Red cell membrane in hemolytic disease: Studies on variables affecting electrophoretic analysis
32. Membrane skeletal alterations during in vivo mouse red cell aging
33. Correlation between protein 4.1 a/4.1b ratio and erythrocyte life span
34. Membrane proteins in senescent erythrocytes
35. Red blood cell associated IgG in normal and pathologic states
36. The selective and conjoint loss of red cell lipids
37. Rate of activation and deactivation of K:Cl cotransport by changes in cell volume in hemoglobin SS, CC and AA red cells
38. Oxidative activation of K-Cl cotransport by diamide in erythrocytes from humans with red cell disorders, and from several other mammalian species
39. Molecular anatomy of the red blood cell membrane skeleton: Structure-function relationships
40. Membrane alterations leading to red cell destruction
41. Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton
42. Release of spectrinfree vesicles fro, human erythrocytes during ATP depletion
43. Glycoprotein topology on intact human red blood cells reevaluated by cross-linking following amino-group supplementation
44. Differential control of band 3 lateral and rotational mobility in intact red cells
45. Increase in band 3 density and aggregation in hereditary spherocytosis
46. Evaluation of biochemical changes during in vivo erythrocyte senescence in the dog
47. Naturally occurring autoantibodies to exoplasmic and cryptic regions of band 3 protein of human red blood cells
48. Senescent red cellbound IgG is attached to band 3 protein
49. Band 3 protein clustering on human erythrocytes promotes binding of naturally occurring anti-band 3 and anti-spectrin antibodies
50. The role of hemoglobin denaturation and band 3 clustering
51. Effect of hemoglobin denaturation on membrane structure and IgG binding: Role in red cell aging
52. Naturally occurring anti-band 3 antibodies and complement together mediate phagocytosis of oxidatively stressed human red blood cells
53. Co-clustering of denatured hemoglobin with band 3: Its role in binding of autoantibodies against band 3 to abnormal and aged erythrocytes
54. Metabolic indicators of oxidative stress correlate with haemichrome attachment to membrane, band 3 aggregation and erythrophagocytosis in beta-thalassaemia intermedia
55. Binding of naturally occurring antibodies to oxidatively and nonoxidatively modified erythrocyte band 3
56. Binding of autologous IgG to human red blood cells before and after ATP-depletion. Selective exposure of binding sites (autoantigens) on spectrin-free vesicles